30
total announcements
MEDANTA.NS · 15 min delayed
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on August 31, 2026, in Noida, where no unpublished price-sensitive information will be shared.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with analysts and institutional investors on August 26 and 27, 2026, to discuss the company's performance and future prospects.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on August 26 and 27, 2026, to be held in a physical mode.
Global Health Limited
Global Health Limited has informed the Exchange about the publication of a newspaper advertisement confirming the dispatch of AGM Notice and Annual Report for the financial year 2025-26.
Global Health Limited
Global Health Limited has informed the Exchange regarding 'Letter to Shareholders' providing the weblink of annual report for the financial year 2025-26.
Global Health Limited
Global Health Limited has published its Business Responsibility and Sustainability Report for the Financial Year 2025-26, as per SEBI Regulation 34(2)(f).
Global Health Limited
Global Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 16, 2026, to consider and adopt audited financial statements, declare final dividend, appoint a director, and approve remuneration payable to cost auditors.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting to be held on August 21, 2026, with FIRST RAY CAPITAL, Singapore, in a virtual one-to-one meeting.
Global Health Limited
Global Health Limited has informed the Exchange about Copy of Newspaper Publication regarding the 22nd Annual General Meeting of the Company scheduled to be held on September 16, 2026, and an e-tender notice for the procurement of distribution transformers.
Global Health Limited
Global Health Limited, also known as Medanta, has informed the Exchange about the transcript of Earnings Conference Call held on July 31, 2026, for the First Quarter ended June 30, 2026 results.
Global Health Limited
Global Health Limited has informed the Exchange about the link of the recording of the earnings conference call held on July 31, 2026, for the First Quarter ended June 30, 2026 financial results.
Global Health Limited
Global Health Limited has published unaudited financial results for the first quarter ended June 30, 2026, in newspapers as required by SEBI regulations.
Global Health Limited
Global Health Limited has informed the Exchange about Investor Presentation for the first quarter ended June 30, 2026 Results. The presentation highlights a revenue growth of 26% y-o-y, primarily led by increase in patient volumes and realization. EBITDA (ex-Noida) grew 23.9% y-o-y to INR 3,201 with improved margins of 25.8% in Q1 FY27. Profit After Tax was INR 1,573 million, compared to INR 1,590 million in Q1FY26.
Global Health Limited
Global Health Limited, one of the largest private multi-specialty tertiary care providers in India, announced its unaudited consolidated financial results for the quarter ending June 30, 2026. The company reported a 26.2% year-over-year growth in total income to INR 13,262 million and a 23.9% year-over-year growth in EBITDA (ex-Noida) to INR 3,201 million with improved margins of 25.8% in Q1 FY27.
Global Health Limited
Global Health Limited has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and has also approved the payment of a final dividend of Rs. 0.50 per equity share for the financial year 2025-26, subject to approval at the 22nd Annual General Meeting.
Global Health Limited
Global Health Limited has informed the Exchange about capacity addition, appointment of Chief Digital Officer, and other board decisions.
Global Health Limited
Global Health Limited has announced a record date of August 14, 2026, for the purpose of determining entitlement of shareholders for the payment of final dividend for the financial year 2025-26. The company has also announced unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and has approved the revised construction plan of its upcoming hospital at Guwahati, increasing the proposed bed capacity from 400 to 650 beds.
Global Health Limited
Global Health Limited has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and has also approved the appointment of a new Chief Digital Officer, Pradeep Kumar Singh, and increased the proposed bed capacity of its upcoming hospital at Guwahati from 400 to 650 beds. The company has also fixed the record date for the payment of final dividend for the financial year 2025-26 and has announced the date for its 22nd Annual General Meeting.
Global Health Limited
Global Health Limited has submitted its unaudited financial results for the first quarter ended June 30, 2026, and announced the approval of the results by its Board of Directors. The company also declared a final dividend of ₹0.50 per equity share for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting.
Global Health Limited
Global Health Limited has informed the Exchange regarding the grant of 20,000 ESOPs to one employee under Part –A of GHL LTIP 2024 Plan.